INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 446m ago
HOUSE PTR46m ago
SEC 13F45m ago
ROBINHOOD CHAIN45m ago
DI
Corporate insider

Delaet Ingrid

Chief Regulatory OfficerCIK 0001965808

EDGAR filingsOpen in network
Disclosed transactions18
Buys / sells0 / 1
Max Insider Score30
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award
A—
4,483 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    NEUROCRINE BIOSCIENCES INCChief Regulatory Officer · Feb 17, 2026
15
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Tax withholding
F
$378K
2,419 sh
Sep 11, 2026
Sep 15, 2026
traded Sep 11, 2026
+4d
SEC FORM 4

Evidence

25
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Open-market sale · 10b5-1 plan
SELL$354K
2,261 sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC FORM 4

Evidence

0
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
2,261 sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC FORM 4

Evidence

6
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Option exercise · 10b5-1 plan
M$179K
2,261 sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC FORM 4

Evidence

30
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Tax withholding
F$1.33M
10.8K sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC FORM 4

Evidence

21
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Option exercise
M—
1,401 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC FORM 4

Evidence

9
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award
A—
31.2K sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC FORM 4

Evidence

17
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Option exercise
M—
1,359 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC FORM 4

Evidence

23
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Option exercise
M—
1,600 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

9
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award
A—
5,479 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC FORM 4

Evidence

23
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Option exercise
M—
1,600 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

22
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Tax withholding
F$108K
881 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

9
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Option exercise
M—
1,359 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC FORM 4

Evidence

17
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Option exercise
M—
1,401 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC FORM 4

Evidence

16
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Tax withholding
F$94K
756 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC FORM 4

Evidence

16
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Tax withholding
F$91K
734 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC FORM 4

Evidence

21
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award
A—
19.9K sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC FORM 4

Evidence